Welcome to LookChem.com Sign In|Join Free

CAS

  • or

195607-61-5

5-Iodobezothiophene-2-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

195607-61-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 195607-61-5 Structure

  • Basic information

    1. Product Name: 5-Iodobezothiophene-2-carboxylic acid
    2. Synonyms: 5-Iodobezothiophene-2-carboxylic acid;5-Iodo-1-benzothiophene-2-carboxylic acid, 2-Carboxy-5-iodobenzo[b]thiophene;5-Iodobenzo[b]thiophene-2-carboxylic acid
    3. CAS NO:195607-61-5
    4. Molecular Formula: C9H5 I O2 S
    5. Molecular Weight: 304.1
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 195607-61-5.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-Iodobezothiophene-2-carboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-Iodobezothiophene-2-carboxylic acid(195607-61-5)
    11. EPA Substance Registry System: 5-Iodobezothiophene-2-carboxylic acid(195607-61-5)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 195607-61-5(Hazardous Substances Data)

195607-61-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 195607-61-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,5,6,0 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 195607-61:
(8*1)+(7*9)+(6*5)+(5*6)+(4*0)+(3*7)+(2*6)+(1*1)=165
165 % 10 = 5
So 195607-61-5 is a valid CAS Registry Number.

195607-61-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-iodo-1-benzothiophene-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-Iodobezothiophene-2-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:195607-61-5 SDS

195607-61-5Relevant articles and documents

METHOD FOR PROMOTING PLANT GROWTH

-

Paragraph 0264, (2015/11/16)

The present invention provides a method for promoting plant growth, which comprises treating a plant with at least one compound selected from a group consisting of a compound represented by the following Formula (1): and an agriculturally acceptable salt thereof, provided that a method for promoting plant growth which comprises treating plants with a compound corresponding to any one of the following (1) to (5) and an agriculturally acceptable salt thereof is excluded: (1) 4-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (2) 5-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (3) 6-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (4) 7-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, and (5) Benzo[b]thiophene-2-carboxylic acid.

Peptide derivatives useful in treating autoimmune diseases

-

, (2008/06/13)

PCT No. PCT/GB97/00438 Sec. 371 Date Aug. 20, 1998 Sec. 102(e) Date Aug. 20, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/31023 PCT Pub. Date Aug. 28, 1997The invention concerns pharmaceutically useful peptide derivatives of the formula (I): P-R1-R2-R3-R4, in which P, R1, R2, R3, and R4 have the various meanings defined herein, and their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The novel peptide derivatives are of value in treating MHC class II dependent T-cell mediated autoimmune or inflammatory diseases, such as rheumatoid arthritis. The invention further concerns processes for the manufacture of the novel peptide derivatives and the use of the compounds in medical treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 195607-61-5